Keyword: patent cliff

News

Alan Hippe to Leave ThyssenKrupp, Will Join Roche as CFO in April

17.01.2011 - Outgoing ThyssenKrupp finance chief Alan Hippe will take up the same position at Roche Holding, replacing Erich Hunziker as the Swiss drugmaker implements cost cuts after a series...

News

Novartis Starts Phase II Trial for Copy of Roche's Rituxan

11.01.2011 - Novartis advanced its bid to copies Roche's multi-billion dollar antibody drug rituximab on Monday, starting phase II trials for its own version of the blockbuster medicine. Drugs...

News

Lamberto Andreotti : Bristol-Myers Poised to Beat Rivals After 2015

07.01.2011 - Bristol-Myers Squibb's growth should beat that of pharmaceutical rivals after 2015 as new drugs revive its earnings, the drugmaker's chief executive said on Thursday. Lamberto...

News

Severin Schwan of Roche Sees Generic Companies and Innovators As Winners

06.12.2010 - Roche Holding Chief Executive Severin Schwan believes the survivors in the pharmaceuticals sector will be large generic drugmakers, and companies who make innovative new products...

News

Novartis: No Plans to Slash Jobs

22.11.2010 - Swiss drugmaker Novartis has no plans to cut thousands of jobs, a spokesman for the company said on Sunday, rebutting a Swiss newspaper report. Sunday newspaper Sonntag said...

News

Biosimilar Antibodies: EU Likely to Be Cautious

17.11.2010 - European regulators are expected to adopt a conservative stance this week when they set rules for allowing copies of antibody drugs, used to fight cancer, rheumatoid arthritis and...

News

Bristol-Myers, Lilly Win Major Drug Patent Rulings

16.11.2010 - U.S. federal judges upheld patents on major drugs marketed by Bristol-Myers Squibb and Eli Lilly and in rulings that would keep generic versions out of the United States for...

News

White Knight Could Be Elusive For Genzyme

02.08.2010 - Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid...